Update: 02.05.2024
Last week: 16 week 2024 (15.04.2024 - 21.04.2024)
Last full month: March 2024
| Time period | Volume, packs | Change, % | MS Volume | Change, p.p. | Value, rur | Change, % | MS Value | Change, p.p. | Cat. Volume Change, % |
|---|---|---|---|---|---|---|---|---|---|
| AMBENE BIO | |||||||||
| WoW | 9 200 | 10.1% | 12.1% | 0.9 | 20 238 336 | 9.5% | 10.2% | 0.8 | 2.1% |
| MoM | 34 128 | 17.0% | 10.5% | -0.5 | 76 805 654 | 16.8% | 9.0% | -0.6 | 23.0% |
| YTD | 116 244 | 23.2% | 11.0% | 2.3 | 260 413 831 | 53.3% | 9.4% | 2.1 | -2.5% |
| MAT | 362 739 | 31.9% | 9.8% | 1.7 | 747 358 757 | 48.2% | 8.3% | 1.4 | 9.0% |
| BRAINMAX | |||||||||
| WoW | 1 203 | 2.7% | 100.0% | 0 | 4 293 097 | 3.2% | 100.0% | 0 | 2.7% |
| MoM | 4 695 | 18.9% | 100.0% | 0 | 17 055 157 | 18.5% | 100.0% | 0 | 21.5% |
| YTD | 16 457 | 55.1% | 100.0% | 0 | 59 214 690 | 65.1% | 100.0% | 0 | 55.1% |
| MAT | 52 500 | 152.5% | 100.0% | NA | 184 357 395 | 168.6% | 100.0% | NA | NA |
| GOLDLINE PLUS | |||||||||
| WoW | 19 849 | 12.5% | 47.0% | 2.2 | 62 137 917 | 9.7% | 38.6% | 2 | 7.3% |
| MoM | 80 084 | 17.2% | 44.7% | 0.9 | 251 582 555 | 15.7% | 36.1% | 0.2 | 14.8% |
| YTD | 271 717 | 1.0% | 44.4% | 2 | 866 339 115 | 6.4% | 36.3% | -2.4 | -3.4% |
| MAT | 871 824 | 16.8% | 45.6% | 2 | 2 743 779 360 | 25.6% | 38.8% | 0.4 | 11.7% |
| MIGRENIUM | |||||||||
| WoW | 14 872 | 5.6% | 0.7% | 0 | 4 722 639 | 6.6% | 0.9% | 0.1 | -1.2% |
| MoM | 52 817 | -0.4% | 0.5% | 0 | 16 070 490 | 6.5% | 0.7% | 0 | 8.6% |
| YTD | 199 786 | 1.8% | 0.6% | -0.1 | 58 106 613 | 64.4% | 0.7% | 0.1 | 19.1% |
| MAT | 645 095 | 8.1% | 0.5% | 0 | 145 424 557 | 34.3% | 0.5% | 0 | 16.4% |
| MODELAX-N | |||||||||
| WoW | 33 028 | 1.7% | 25.3% | 0 | 14 355 597 | 3.0% | 16.8% | 0.4 | 1.7% |
| MoM | 164 685 | 26.9% | 27.3% | 4.3 | 68 795 771 | 29.7% | 17.5% | 3.3 | 6.8% |
| YTD | 512 671 | 57.1% | 23.8% | 6 | 211 351 251 | 105.2% | 14.9% | 4.7 | 17.9% |
| MAT | 1 354 375 | 103.9% | 20.5% | 8 | 491 158 872 | 126.1% | 12.0% | 4.8 | 24.3% |
| REDUXIN | |||||||||
| WoW | 13 718 | 5.5% | 32.5% | -0.6 | 72 048 447 | 0.8% | 44.7% | -1.4 | 7.3% |
| MoM | 58 968 | 14.9% | 32.9% | 0 | 324 783 811 | 17.2% | 46.6% | 0.9 | 14.8% |
| YTD | 202 785 | -8.3% | 33.1% | -1.7 | 1 103 670 048 | 22.7% | 46.2% | 3.5 | -3.4% |
| MAT | 619 574 | 1.5% | 32.4% | -3.2 | 3 077 008 969 | 22.1% | 43.6% | -0.7 | 11.7% |
| REDUXIN FORTE | |||||||||
| WoW | 3 568 | 5.9% | 8.4% | -0.1 | 15 414 767 | 7.6% | 9.6% | 0.3 | 7.3% |
| MoM | 15 469 | 9.3% | 8.6% | -0.4 | 66 626 856 | 4.4% | 9.6% | -1 | 14.8% |
| YTD | 53 051 | 4.9% | 8.7% | 0.7 | 231 995 873 | 23.1% | 9.7% | 0.8 | -3.4% |
| MAT | 168 489 | 27.0% | 8.8% | 1.1 | 697 028 664 | 38.9% | 9.9% | 1 | 11.7% |
| SALVISAR | |||||||||
| WoW | 14 750 | 2.2% | 1.8% | 0 | 6 108 073 | 1.3% | 1.6% | 0 | 2.8% |
| MoM | 51 767 | 46.5% | 1.5% | 0.4 | 20 518 388 | 55.8% | 1.4% | 0.4 | 8.3% |
| YTD | 162 084 | -6.7% | 1.3% | -0.2 | 62 293 659 | 11.3% | 1.2% | -0.1 | 5.8% |
| MAT | 486 680 | -18.9% | 1.2% | -0.4 | 170 067 697 | -16.7% | 1.0% | -0.4 | 7.8% |
| Brand | Volume, packs | Change, % | MS Volume | Change, p.p. | Value, rur | Change, % | MS Value | Change, p.p. | Cat. Volume Change, % |
|---|---|---|---|---|---|---|---|---|---|
| AMBENE BIO | 116 244 | 23.2% | 11.0% | 2.3 | 260 413 831 | 53.3% | 9.4% | 2.1 | -2.5% |
| BRAINMAX | 16 457 | 55.1% | 100.0% | 0 | 59 214 690 | 65.1% | 100.0% | 0 | 55.1% |
| GOLDLINE PLUS | 271 717 | 1.0% | 44.4% | 2 | 866 339 115 | 6.4% | 36.3% | -2.4 | -3.4% |
| MIGRENIUM | 199 786 | 1.8% | 0.6% | -0.1 | 58 106 613 | 64.4% | 0.7% | 0.1 | 19.1% |
| MODELAX-N | 512 671 | 57.1% | 23.8% | 6 | 211 351 251 | 105.2% | 14.9% | 4.7 | 17.9% |
| REDUXIN CAPS | 202 785 | -8.3% | 33.1% | -1.7 | 1 103 670 048 | 22.7% | 46.2% | 3.5 | -3.4% |
| REDUXIN FORTE | 53 051 | 4.9% | 8.7% | 0.7 | 231 995 873 | 23.1% | 9.7% | 0.8 | -3.4% |
| SALVISAR | 162 084 | -6.7% | 1.3% | -0.2 | 62 293 659 | 11.3% | 1.2% | -0.1 | 5.8% |
| Brand | Volume, packs | Change, % | MS Volume | Change, p.p. | Value, rur | Change, % | MS Value | Change, p.p. | Cat. Volume Change, % |
|---|---|---|---|---|---|---|---|---|---|
| AMBENE BIO | 362 739 | 31.9% | 9.8% | 1.7 | 747 358 757 | 48.2% | 8.3% | 1.4 | 9.0% |
| BRAINMAX | 52 500 | 152.5% | 100.0% | NA | 184 357 395 | 168.6% | 100.0% | NA | NA |
| GOLDLINE PLUS | 871 824 | 16.8% | 45.6% | 2 | 2 743 779 360 | 25.6% | 38.8% | 0.4 | 11.7% |
| MIGRENIUM | 645 095 | 8.1% | 0.5% | 0 | 145 424 557 | 34.3% | 0.5% | 0 | 16.4% |
| MODELAX-N | 1 354 375 | 103.9% | 20.5% | 8 | 491 158 872 | 126.1% | 12.0% | 4.8 | 24.3% |
| REDUXIN CAPS | 619 574 | 1.5% | 32.4% | -3.2 | 3 077 008 969 | 22.1% | 43.6% | -0.7 | 11.7% |
| REDUXIN FORTE | 168 489 | 27.0% | 8.8% | 1.1 | 697 028 664 | 38.9% | 9.9% | 1 | 11.7% |
| SALVISAR | 486 680 | -18.9% | 1.2% | -0.4 | 170 067 697 | -16.7% | 1.0% | -0.4 | 7.8% |
| Brand | Volume, packs | Change, % | MS Volume | Change, p.p. | Value, rur | Change, % | MS Value | Change, p.p. | Cat. Volume Change, % |
|---|---|---|---|---|---|---|---|---|---|
| AMBENE BIO | 9 200 | 10.1% | 12.1% | 0.9 | 20 238 336 | 9.5% | 10.2% | 0.8 | 2.1% |
| BRAINMAX | 1 203 | 2.7% | 100.0% | 0 | 4 293 097 | 3.2% | 100.0% | 0 | 2.7% |
| GOLDLINE PLUS | 19 849 | 12.5% | 47.0% | 2.2 | 62 137 917 | 9.7% | 38.6% | 2 | 7.3% |
| MIGRENIUM | 14 872 | 5.6% | 0.7% | 0 | 4 722 639 | 6.6% | 0.9% | 0.1 | -1.2% |
| MODELAX-N | 33 028 | 1.7% | 25.3% | 0 | 14 355 597 | 3.0% | 16.8% | 0.4 | 1.7% |
| REDUXIN CAPS | 13 718 | 5.5% | 32.5% | -0.6 | 72 048 447 | 0.8% | 44.7% | -1.4 | 7.3% |
| REDUXIN FORTE | 3 568 | 5.9% | 8.4% | -0.1 | 15 414 767 | 7.6% | 9.6% | 0.3 | 7.3% |
| SALVISAR | 14 750 | 2.2% | 1.8% | 0 | 6 108 073 | 1.3% | 1.6% | 0 | 2.8% |
| Brand | Volume, packs | Change, % | MS Volume | Change, p.p. | Value, rur | Change, % | MS Value | Change, p.p. | Cat. Volume Change, % |
|---|---|---|---|---|---|---|---|---|---|
| AMBENE BIO | 34 128 | 17.0% | 10.5% | -0.5 | 76 805 654 | 16.8% | 9.0% | -0.6 | 23.0% |
| BRAINMAX | 4 695 | 18.9% | 100.0% | 0 | 17 055 157 | 18.5% | 100.0% | 0 | 21.5% |
| GOLDLINE PLUS | 80 084 | 17.2% | 44.7% | 0.9 | 251 582 555 | 15.7% | 36.1% | 0.2 | 14.8% |
| MIGRENIUM | 52 817 | -0.4% | 0.5% | 0 | 16 070 490 | 6.5% | 0.7% | 0 | 8.6% |
| MODELAX-N | 164 685 | 26.9% | 27.3% | 4.3 | 68 795 771 | 29.7% | 17.5% | 3.3 | 6.8% |
| REDUXIN CAPS | 58 968 | 14.9% | 32.9% | 0 | 324 783 811 | 17.2% | 46.6% | 0.9 | 14.8% |
| REDUXIN FORTE | 15 469 | 9.3% | 8.6% | -0.4 | 66 626 856 | 4.4% | 9.6% | -1 | 14.8% |
| SALVISAR | 51 767 | 46.5% | 1.5% | 0.4 | 20 518 388 | 55.8% | 1.4% | 0.4 | 8.3% |
ОБОЗНАЧЕНИЯ
WoW - Week Over Week - показатели для сравнения результатов текущей и предыдущей недели
MoM - Month Over Month - показатели для сравнения результатов последнего полного месяца и предыдущего полного месяца
YTD - Year to Date - показатели для сравнения результатов за период времени, начинающийся с первого дня текущего календарного года до текущей даты с результатами за сопоставимый период прошлого года
MAT - Moving Annual Total - показатели для сравнения результатов за период 12 месяцев, с датой окончания на последней доступной неделе, с результатами за сопоставимый период прошлого года
MS - Market Share - Доля рынка = (Продажи бренда / Продажи категории)*100%
Change, % = (Продажи бренда за последний период / Продажи бренда за предыдущий период - 1)*100%
Change, p.p. = Доля бренда на рынке за последний период - Доля бренда на рынке за предыдущий период (выражается в процентных пунктах)
Cat. Volume Change, % = (Продажи категории в упаковках за последний период / Продажи категории в упаковках за предыдущий период - 1)*100%
Каждая категория собрана специально для каждого бренда и включает в себя бренд и его конкурентов
Список конкурентов можно найти в разделе "MS of competitors" в блоке каждого бренда
ABBREVIATIONS
WoW - Week Over Week - indicators for comparing the results of the current and previous week
MoM - Month Over Month - indicators for comparing the results of the* last full month* and previous full month
YTD - Year to Date - indicators for comparing the results of the period of time beginning the first day of the current calendar year up to the current date with the results of the comparable period last year
MAT - Moving Annual Total - indicators for comparing the results of the period, being 12 month period ending on the last week with the results of the comparable period last year
MS - Market Share - (Brand Sales / Category Sales)*100%
Change, % = (Brand Sales of the last period / Brand Sales of the previous period - 1)*100%
Change, p.p. = Brand Market Share of the last period - Brand Market Share of the previous period (expressed in percentage points)
Cat. Volume Change, % = (Category Sales in packs of the last period / Category Sales in packs of the previous period - 1)*100%
Each category is created specifically for each brand and includes the brand and its competitors
The list of competitors can be found in the subsection "MS of competitors" in sections for each brand
## [1] "MODELAX-N"
## [1] "MODELAX-N SOL RECTAL USE 5 ML #2"
## [1] "MODELAX-N SOL RECTAL USE 5 ML #4"
## [1] "MODELAX-N SOL RECTAL USE 5 ML #8"
## [1] "MODELAX-N"
## [1] "MODELAX-N SOL RECTAL USE 5 ML #2"
## [1] "MODELAX-N SOL RECTAL USE 5 ML #4"
## [1] "MODELAX-N SOL RECTAL USE 5 ML #8"
## [1] "AMBENE BIO"
## [1] "AMBENE BIO SOL FOR INJ 1 ML #10"
## [1] "AMBENE BIO SOL FOR INJ 2 ML #5"
## [1] "AMBENE BIO"
## [1] "AMBENE BIO SOL FOR INJ 1 ML #10"
## [1] "AMBENE BIO SOL FOR INJ 2 ML #5"
## [1] "MIGRENIUM"
## [1] "MIGRENIUM COATED TABLETS 65 MG+500 MG #20"
## [1] "MIGRENIUM"
## [1] "MIGRENIUM COATED TABLETS 65 MG+500 MG #20"
## [1] "SALVISAR"
## [1] "SALVISAR UNGUENT FOR EXT USE 100 G #1"
## [1] "SALVISAR UNGUENT FOR EXT USE 25 G #1"
## [1] "SALVISAR UNGUENT FOR EXT USE 25 G #2"
## [1] "SALVISAR UNGUENT FOR EXT USE 50 G #1"
## [1] "SALVISAR"
## [1] "SALVISAR UNGUENT FOR EXT USE 100 G #1"
## [1] "SALVISAR UNGUENT FOR EXT USE 25 G #1"
## [1] "SALVISAR UNGUENT FOR EXT USE 25 G #2"
## [1] "SALVISAR UNGUENT FOR EXT USE 50 G #1"
## [1] "REDUXIN CAPS"
## [1] "REDUXIN CAPS 10 MG+158,5 MG #10"
## [1] "REDUXIN CAPS 10 MG+158,5 MG #30"
## [1] "REDUXIN CAPS 10 MG+158,5 MG #60"
## [1] "REDUXIN CAPS 10 MG+158,5 MG #60"
## [1] "REDUXIN CAPS 10 MG+158,5 MG #60"
## [1] "REDUXIN CAPS 15 MG+153,5 MG #30"
## [1] "REDUXIN CAPS 15 MG+153,5 MG #60"
## [1] "REDUXIN CAPS 15 MG+153,5 MG #90"
## [1] "REDUXIN CAPS"
## [1] "REDUXIN CAPS 10 MG+158,5 MG #10"
## [1] "REDUXIN CAPS 10 MG+158,5 MG #30"
## [1] "REDUXIN CAPS 10 MG+158,5 MG #60"
## [1] "REDUXIN CAPS 10 MG+158,5 MG #90"
## [1] "REDUXIN CAPS 15 MG+153,5 MG #10"
## [1] "REDUXIN CAPS 15 MG+153,5 MG #30"
## [1] "REDUXIN CAPS 15 MG+153,5 MG #60"
## [1] "REDUXIN CAPS 15 MG+153,5 MG #90"
## [1] "REDUXIN FORTE"
## [1] "REDUXIN FORTE COATED TABLETS 850 MG+15 MG #30"
## [1] "REDUXIN FORTE COATED TABLETS 850 MG+15 MG #60"
## [1] "REDUXIN FORTE COATED TABLETS 850 MG+15 MG #90"
## [1] "REDUXIN FORTE COATED TABLETS 850 MG+15 MG #90"
## [1] "REDUXIN FORTE COATED TABLETS 850 MG+15 MG #90"
## [1] "REDUXIN FORTE TABS 850 MG + 10 MG #90"
## [1] "REDUXIN FORTE"
## [1] "REDUXIN FORTE COATED TABLETS 850 MG+15 MG #30"
## [1] "REDUXIN FORTE COATED TABLETS 850 MG+15 MG #60"
## [1] "REDUXIN FORTE COATED TABLETS 850 MG+15 MG #90"
## [1] "REDUXIN FORTE TABS 850 MG + 10 MG #30"
## [1] "REDUXIN FORTE TABS 850 MG + 10 MG #60"
## [1] "REDUXIN FORTE TABS 850 MG + 10 MG #90"
## [1] "GOLDLINE PLUS"
## [1] "GOLDLINE PLUS CAPS 10 MG+158,5 MG #10"
## [1] "GOLDLINE PLUS CAPS 10 MG+158,5 MG #30"
## [1] "GOLDLINE PLUS CAPS 10 MG+158,5 MG #60"
## [1] "GOLDLINE PLUS CAPS 10 MG+158,5 MG #60"
## [1] "GOLDLINE PLUS CAPS 10 MG+158,5 MG #60"
## [1] "GOLDLINE PLUS CAPS 15 MG+153,5 MG #30"
## [1] "GOLDLINE PLUS CAPS 15 MG+153,5 MG #60"
## [1] "GOLDLINE PLUS CAPS 15 MG+153,5 MG #90"
## [1] "GOLDLINE PLUS"
## [1] "GOLDLINE PLUS CAPS 10 MG+158,5 MG #10"
## [1] "GOLDLINE PLUS CAPS 10 MG+158,5 MG #30"
## [1] "GOLDLINE PLUS CAPS 10 MG+158,5 MG #60"
## [1] "GOLDLINE PLUS CAPS 10 MG+158,5 MG #90"
## [1] "GOLDLINE PLUS CAPS 15 MG+153,5 MG #10"
## [1] "GOLDLINE PLUS CAPS 15 MG+153,5 MG #30"
## [1] "GOLDLINE PLUS CAPS 15 MG+153,5 MG #60"
## [1] "GOLDLINE PLUS CAPS 15 MG+153,5 MG #90"
## [1] "BRAINMAX SOL FOR INTRAVEN&INTRAMUSC INJ 100 MG/ML+100 MG/ML 2,5 ML #10"
## [1] "BRAINMAX CAPS 250 MG+250 MG #40"
## [1] "BRAINMAX CAPS 250 MG+250 MG #60"
## [1] "BRAINMAX SOL FOR INTRAVEN&INTRAMUSC INJ 100 MG/ML+100 MG/ML 2,5 ML #10"
## [1] "BRAINMAX SOL FOR INTRAVEN&INTRAMUSC INJ 100 MG/ML+100 MG/ML 5 ML #10"
## [1] "BRAINMAX"
## [1] "BRAINMAX CAPS 250 MG+250 MG #40"
## [1] "BRAINMAX CAPS 250 MG+250 MG #60"
## [1] "BRAINMAX SOL FOR INTRAVEN&INTRAMUSC INJ 100 MG/ML+100 MG/ML 2,5 ML #10"
## [1] "BRAINMAX SOL FOR INTRAVEN&INTRAMUSC INJ 100 MG/ML+100 MG/ML 5 ML #10"
[RUS] ОБОЗНАЧЕНИЯ
WoW - Week Over Week - показатели для сравнения результатов текущей и предыдущей недели
MoM - Month Over Month - показатели для сравнения результатов последнего полного месяца и предыдущего полного месяца
YTD - Year to Date - показатели для сравнения результатов за период времени, начинающийся с первого дня текущего календарного года до текущей даты с результатами за сопоставимый период прошлого года
MAT - Moving Annual Total - показатели для сравнения результатов за период 12 месяцев, с датой окончания на последней доступной неделе, с результатами за сопоставимый период прошлого года
MS - Market Share - Доля рынка = (Продажи бренда / Продажи категории)*100%
Change, % = (Продажи бренда за последний период / Продажи бренда за предыдущий период - 1)*100%
Change, p.p. = Доля бренда на рынке за последний период - Доля бренда на рынке за предыдущий период (выражается в процентных пунктах)
Cat. Volume Change, % = (Продажи категории в упаковках за последний период / Продажи категории в упаковках за предыдущий период - 1)*100%
Каждая категория собрана специально для каждого бренда и включает в себя бренд и его конкурентов
Список конкурентов можно найти в разделе "MS of competitors" в блоке каждого бренда
[ENG] ABBREVIATIONS
WoW - Week Over Week - indicators for comparing the results of the current and previous week
MoM - Month Over Month - indicators for comparing the results of the last full month and previous full month
YTD - Year to Date - indicators for comparing the results of the period of time beginning the first day of the current calendar year up to the current date with the results of the comparable period last year
MAT - Moving Annual Total - indicators for comparing the results of the period, being 12 month period ending on the last week with the results of the comparable period last year
MS - Market Share - (Brand Sales / Category Sales)*100%
Change, % = (Brand Sales of the last period / Brand Sales of the previous period - 1)*100%
Change, p.p. = Brand Market Share of the last period - Brand Market Share of the previous period (expressed in percentage points)
Cat. Volume Change, % = (Category Sales in packs of the last period / Category Sales in packs of the previous period - 1)*100%
Each category is created specifically for each brand and includes the brand and its competitors
The list of competitors can be found in the subsection "MS of competitors" in sections for each brand
DATA SOURCES:
DSM: Sales
Palomars: TRPs